Cargando…

The small molecule indirubin-3′-oxime activates Wnt/β-catenin signaling and inhibits adipocyte differentiation and obesity

OBJECTIVES: Activation of the Wnt/β-catenin signaling pathway inhibits adipogenesis by maintaining preadipocytes in an undifferentiated state. We investigated the effect of indirubin-3′-oxime (I3O), which was screened as an activator of the Wnt/β-catenin signaling, on inhibiting the preadipocyte dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, O M, Cho, Y-H, Choi, S, Lee, S-H, Seo, S H, Kim, H-Y, Han, G, Min, D S, Park, T, Choi, K Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125748/
https://www.ncbi.nlm.nih.gov/pubmed/24232498
http://dx.doi.org/10.1038/ijo.2013.209
_version_ 1782329792055476224
author Choi, O M
Cho, Y-H
Choi, S
Lee, S-H
Seo, S H
Kim, H-Y
Han, G
Min, D S
Park, T
Choi, K Y
author_facet Choi, O M
Cho, Y-H
Choi, S
Lee, S-H
Seo, S H
Kim, H-Y
Han, G
Min, D S
Park, T
Choi, K Y
author_sort Choi, O M
collection PubMed
description OBJECTIVES: Activation of the Wnt/β-catenin signaling pathway inhibits adipogenesis by maintaining preadipocytes in an undifferentiated state. We investigated the effect of indirubin-3′-oxime (I3O), which was screened as an activator of the Wnt/β-catenin signaling, on inhibiting the preadipocyte differentiation in vitro and in vivo. METHODS: 3T3L1 preadipocytes were differentiated with 0, 4 or 20 μM of I3O. The I3O effect on adipocyte differentiation was observed by Oil-red-O staining. Activation of Wnt/β-catenin signaling in I3O-treated 3T3L1 cells was shown using immunocytochemical and immunoblotting analyses for β-catenin. The regulation of adipogenic markers was analyzed via real-time reverse transcription-PCR (RT-PCR) and immunoblotting analyses. For the in vivo study, mice were divided into five different dietary groups: chow diet, high-fat diet (HFD), HFD supplemented with I3O at 5, 25 and 100 mg kg(−1). After 8 weeks, adipose and liver tissues were excised from the mice and subject to morphometry, real-time RT-PCR, immunoblotting and histological or immunohistochemical analyses. In addition, adipokine and insulin concentrations in serum of the mice were accessed by enzyme-linked immunosorbent assay. RESULTS: Using a cell-based approach to screen a library of pharmacologically active small molecules, we identified I3O as a Wnt/β-catenin pathway activator. I3O inhibited the differentiation of 3T3-L1 cells into mature adipocytes and decreased the expression of adipocyte markers, CCAAT/enhancer-binding protein α and peroxisome proliferator-activated receptor γ, at both mRNA and protein levels. In vivo, I3O inhibited the development of obesity in HFD-fed mice by attenuating HFD-induced body weight gain and visceral fat accumulation without showing any significant toxicity. Factors associated with metabolic disorders such as hyperlipidemia and hyperglycemia were also improved by treatment of I3O. CONCLUSION: Activation of the Wnt/β-catenin signaling pathway can be used as a therapeutic strategy for the treatment of obesity and metabolic syndrome and implicates I3O as a candidate anti-obesity agent.
format Online
Article
Text
id pubmed-4125748
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-41257482014-08-14 The small molecule indirubin-3′-oxime activates Wnt/β-catenin signaling and inhibits adipocyte differentiation and obesity Choi, O M Cho, Y-H Choi, S Lee, S-H Seo, S H Kim, H-Y Han, G Min, D S Park, T Choi, K Y Int J Obes (Lond) Original Article OBJECTIVES: Activation of the Wnt/β-catenin signaling pathway inhibits adipogenesis by maintaining preadipocytes in an undifferentiated state. We investigated the effect of indirubin-3′-oxime (I3O), which was screened as an activator of the Wnt/β-catenin signaling, on inhibiting the preadipocyte differentiation in vitro and in vivo. METHODS: 3T3L1 preadipocytes were differentiated with 0, 4 or 20 μM of I3O. The I3O effect on adipocyte differentiation was observed by Oil-red-O staining. Activation of Wnt/β-catenin signaling in I3O-treated 3T3L1 cells was shown using immunocytochemical and immunoblotting analyses for β-catenin. The regulation of adipogenic markers was analyzed via real-time reverse transcription-PCR (RT-PCR) and immunoblotting analyses. For the in vivo study, mice were divided into five different dietary groups: chow diet, high-fat diet (HFD), HFD supplemented with I3O at 5, 25 and 100 mg kg(−1). After 8 weeks, adipose and liver tissues were excised from the mice and subject to morphometry, real-time RT-PCR, immunoblotting and histological or immunohistochemical analyses. In addition, adipokine and insulin concentrations in serum of the mice were accessed by enzyme-linked immunosorbent assay. RESULTS: Using a cell-based approach to screen a library of pharmacologically active small molecules, we identified I3O as a Wnt/β-catenin pathway activator. I3O inhibited the differentiation of 3T3-L1 cells into mature adipocytes and decreased the expression of adipocyte markers, CCAAT/enhancer-binding protein α and peroxisome proliferator-activated receptor γ, at both mRNA and protein levels. In vivo, I3O inhibited the development of obesity in HFD-fed mice by attenuating HFD-induced body weight gain and visceral fat accumulation without showing any significant toxicity. Factors associated with metabolic disorders such as hyperlipidemia and hyperglycemia were also improved by treatment of I3O. CONCLUSION: Activation of the Wnt/β-catenin signaling pathway can be used as a therapeutic strategy for the treatment of obesity and metabolic syndrome and implicates I3O as a candidate anti-obesity agent. Nature Publishing Group 2014-08 2013-12-10 /pmc/articles/PMC4125748/ /pubmed/24232498 http://dx.doi.org/10.1038/ijo.2013.209 Text en Copyright © 2014 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Original Article
Choi, O M
Cho, Y-H
Choi, S
Lee, S-H
Seo, S H
Kim, H-Y
Han, G
Min, D S
Park, T
Choi, K Y
The small molecule indirubin-3′-oxime activates Wnt/β-catenin signaling and inhibits adipocyte differentiation and obesity
title The small molecule indirubin-3′-oxime activates Wnt/β-catenin signaling and inhibits adipocyte differentiation and obesity
title_full The small molecule indirubin-3′-oxime activates Wnt/β-catenin signaling and inhibits adipocyte differentiation and obesity
title_fullStr The small molecule indirubin-3′-oxime activates Wnt/β-catenin signaling and inhibits adipocyte differentiation and obesity
title_full_unstemmed The small molecule indirubin-3′-oxime activates Wnt/β-catenin signaling and inhibits adipocyte differentiation and obesity
title_short The small molecule indirubin-3′-oxime activates Wnt/β-catenin signaling and inhibits adipocyte differentiation and obesity
title_sort small molecule indirubin-3′-oxime activates wnt/β-catenin signaling and inhibits adipocyte differentiation and obesity
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125748/
https://www.ncbi.nlm.nih.gov/pubmed/24232498
http://dx.doi.org/10.1038/ijo.2013.209
work_keys_str_mv AT choiom thesmallmoleculeindirubin3oximeactivateswntbcateninsignalingandinhibitsadipocytedifferentiationandobesity
AT choyh thesmallmoleculeindirubin3oximeactivateswntbcateninsignalingandinhibitsadipocytedifferentiationandobesity
AT chois thesmallmoleculeindirubin3oximeactivateswntbcateninsignalingandinhibitsadipocytedifferentiationandobesity
AT leesh thesmallmoleculeindirubin3oximeactivateswntbcateninsignalingandinhibitsadipocytedifferentiationandobesity
AT seosh thesmallmoleculeindirubin3oximeactivateswntbcateninsignalingandinhibitsadipocytedifferentiationandobesity
AT kimhy thesmallmoleculeindirubin3oximeactivateswntbcateninsignalingandinhibitsadipocytedifferentiationandobesity
AT hang thesmallmoleculeindirubin3oximeactivateswntbcateninsignalingandinhibitsadipocytedifferentiationandobesity
AT minds thesmallmoleculeindirubin3oximeactivateswntbcateninsignalingandinhibitsadipocytedifferentiationandobesity
AT parkt thesmallmoleculeindirubin3oximeactivateswntbcateninsignalingandinhibitsadipocytedifferentiationandobesity
AT choiky thesmallmoleculeindirubin3oximeactivateswntbcateninsignalingandinhibitsadipocytedifferentiationandobesity
AT choiom smallmoleculeindirubin3oximeactivateswntbcateninsignalingandinhibitsadipocytedifferentiationandobesity
AT choyh smallmoleculeindirubin3oximeactivateswntbcateninsignalingandinhibitsadipocytedifferentiationandobesity
AT chois smallmoleculeindirubin3oximeactivateswntbcateninsignalingandinhibitsadipocytedifferentiationandobesity
AT leesh smallmoleculeindirubin3oximeactivateswntbcateninsignalingandinhibitsadipocytedifferentiationandobesity
AT seosh smallmoleculeindirubin3oximeactivateswntbcateninsignalingandinhibitsadipocytedifferentiationandobesity
AT kimhy smallmoleculeindirubin3oximeactivateswntbcateninsignalingandinhibitsadipocytedifferentiationandobesity
AT hang smallmoleculeindirubin3oximeactivateswntbcateninsignalingandinhibitsadipocytedifferentiationandobesity
AT minds smallmoleculeindirubin3oximeactivateswntbcateninsignalingandinhibitsadipocytedifferentiationandobesity
AT parkt smallmoleculeindirubin3oximeactivateswntbcateninsignalingandinhibitsadipocytedifferentiationandobesity
AT choiky smallmoleculeindirubin3oximeactivateswntbcateninsignalingandinhibitsadipocytedifferentiationandobesity